"XBB" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonReal-World Data Highlight Effectiveness of XBB.1.5-Adapted COVID-19 Vaccines - Vaccine Advisor
Real-World Data Highlight Effectiveness of XBB.1.5-Adapted COVID-19 Vaccines Vaccine Advisor
Protocol to measure COVID-19 XBB.1.5 vaccine effectiveness in the immunocompromised population du...
Protocol to measure COVID-19 XBB.1.5 vaccine effectiveness in the immunocompromised population during the 2023 autumn vaccination campaign European Centre for Disease Prevention and Control
(XBB) Strategic Market Analysis (XBB:CA) - Stock Traders Daily
(XBB) Strategic Market Analysis (XBB:CA) Stock Traders Daily
Immune imprinting toward SARS-CoV-2 XBB: implications for vaccine strategy and variant risk asses...
The World's First Fixed Income ETFs Turn 25 - ETF Trends
The World's First Fixed Income ETFs Turn 25 ETF Trends
Types of data requested to inform December 2025 COVID-19 vaccine antigen composition deliberation...
Types of data requested to inform December 2025 COVID-19 vaccine antigen composition deliberations World Health Organization (WHO)
New COVID variant NB.1.8.1 spreads across continents amid calls for vigilance - News-Medical
New COVID variant NB.1.8.1 spreads across continents amid calls for vigilance News-Medical
Evaluating the safety of XBB.1.5-containing COVID-19 mRNA vaccines using a self-controlled case s...
XBB: Innovative Fund From BondBloxx, But Spreads Are Too Tight - Seeking Alpha
XBB: Innovative Fund From BondBloxx, But Spreads Are Too Tight Seeking Alpha
Using surveillance data to evaluate the effectiveness of inactivated/mRNA COVID-19 vaccine booste...
XBB.1.5 monovalent vaccine induces lasting cross-reactive responses to SARS-CoV-2 variants such a...
Omicron XBB Insights Could Shape Future COVID-19 Vaccine Design - Duke School of Medicine
Omicron XBB Insights Could Shape Future COVID-19 Vaccine Design Duke School of Medicine
XBB.1.5 Omicron subvariant: Questions patients may have - American Medical Association
XBB.1.5 Omicron subvariant: Questions patients may have American Medical Association
TAG-VE statement on Omicron sublineages BQ.1 and XBB - World Health Organization (WHO)
TAG-VE statement on Omicron sublineages BQ.1 and XBB World Health Organization (WHO)
Determinants of antibody levels and protection against omicron BQ.1/XBB breakthrough infection - ...
Determinants of antibody levels and protection against omicron BQ.1/XBB breakthrough infection Nature
Neutralizing antibody durability and SARS-CoV-2 infection in older adults six months after XBB-co...
Immune imprinting and vaccine interval determine antibody responses to monovalent XBB.1.5 COVID-1...
Multiple infections with Omicron variants increase breadth and potency of Omicron-specific neutra...
Potent bivalent nanobody constructs that protect against the SARS-CoV-2 XBB variant - Nature
Potent bivalent nanobody constructs that protect against the SARS-CoV-2 XBB variant Nature
Humoral immunity and clinical characteristics of Chinese college students experiencing a BA.5/BF....
What You Need to Know About XBB.1.5, the Latest Omicron Variant - Johns Hopkins Bloomberg School ...
What You Need to Know About XBB.1.5, the Latest Omicron Variant Johns Hopkins Bloomberg School of Public Health
CDC: Updated COVID-19 booster helps protect against omicron XBB variants | AHA News - American Ho...
CDC: Updated COVID-19 booster helps protect against omicron XBB variants | AHA News American Hospital Association
Durability of XBB.1.5 Vaccines against Omicron Subvariants - New England Journal of Medicine
Durability of XBB.1.5 Vaccines against Omicron Subvariants New England Journal of Medicine
Effectiveness of BNT162b2 XBB vaccine in the US Veterans Affairs Healthcare System - Nature
Effectiveness of BNT162b2 XBB vaccine in the US Veterans Affairs Healthcare System Nature
Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine | npj Vacci...
Preclinical characterization of the Omicron XBB.1.5-adapted BNT162b2 COVID-19 vaccine | npj Vaccines Nature
Genomic Surveillance for SARS-CoV-2 Variants: ... - Centers for Disease Control and Prevention | ...
Genomic Surveillance for SARS-CoV-2 Variants: ... Centers for Disease Control and Prevention | CDC (.gov)
Interim Effectiveness of Updated 2023–2024 ... - Centers for Disease Control and Prevention | CDC...
Interim Effectiveness of Updated 2023–2024 ... Centers for Disease Control and Prevention | CDC (.gov)
Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicr...
What to know about XBB.1.5, a new and highly transmissible COVID-19 subvariant - PBS
What to know about XBB.1.5, a new and highly transmissible COVID-19 subvariant PBS
Early Estimates of Updated 2023–2024 (Monovalent XBB.1.5) ... - Centers for Disease Control and P...
Early Estimates of Updated 2023–2024 (Monovalent XBB.1.5) ... Centers for Disease Control and Prevention | CDC (.gov)
Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB - New England Journal of ...
Efficacy of Antiviral Agents against Omicron Subvariants BQ.1.1 and XBB New England Journal of Medicine
Distinct evolution of SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 lineages combining increased fitnes...
COVID-19 XBB-Adapted Vaccine Less Effective Against JN.1 vs XBB Sublineages - Infectious Disease ...
COVID-19 XBB-Adapted Vaccine Less Effective Against JN.1 vs XBB Sublineages Infectious Disease Advisor
Rising cases of COVID-19 variant, XBB.1.5 - Mayo Clinic News Network
Rising cases of COVID-19 variant, XBB.1.5 Mayo Clinic News Network
Evolving antibody response to SARS-CoV-2 antigenic shift from XBB to JN.1 - Nature
Evolving antibody response to SARS-CoV-2 antigenic shift from XBB to JN.1 Nature
Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1 - New England J...
Substantial Neutralization Escape by SARS-CoV-2 Omicron Variants BQ.1.1 and XBB.1 New England Journal of Medicine
WHO tracking Omicron XBB.1.16 subvariant, rising cases in some countries - CIDRAP
WHO tracking Omicron XBB.1.16 subvariant, rising cases in some countries CIDRAP
Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster - New England Journa...
Neutralization against BA.2.75.2, BQ.1.1, and XBB from mRNA Bivalent Booster New England Journal of Medicine
Effect of XBB.1.5-adapted booster vaccination on the imprinting of SARS-CoV-2 immunity | npj Vacc...
Not just Singapore: The highly immune-evasive XBB COVID variant has been identified in 26 countri...
XBB.1.5 spike protein COVID-19 vaccine induces broadly neutralizing and cellular immune responses...
US COVID markers continue upward trend as newer XBB variant proportions grow - CIDRAP
US COVID markers continue upward trend as newer XBB variant proportions grow CIDRAP
The emergence of the Omicron XBB.1.5 variant in India: a brief report on clinical presentation of...
What We Know About Omicron XBB - Torrance Memorial Medical Center
What We Know About Omicron XBB Torrance Memorial Medical Center
Immunogenicity and safety of a monovalent omicron XBB.1.5 SARS-CoV-2 recombinant spike protein va...
The rise of variant XBB.1.5, and more — this week’s best science graphics - Nature
The rise of variant XBB.1.5, and more — this week’s best science graphics Nature
Don’t believe warning about ‘different and deadly’ coronavirus ‘XBB variant’ – old false story ci...
Don’t believe warning about ‘different and deadly’ coronavirus ‘XBB variant’ – old false story circulating again Africa Check
WHO weighs in on Omicron XBB.1.5 subvariant; US extends COVID health emergency - CIDRAP
WHO weighs in on Omicron XBB.1.5 subvariant; US extends COVID health emergency CIDRAP
XBB.1.5: What You Need to Know About COVID-19’s ‘Kraken’ Variant - UC Davis
XBB.1.5: What You Need to Know About COVID-19’s ‘Kraken’ Variant UC Davis
Arcturus: WHO upgrades XBB.1.16 to a COVID-19 “variant of interest” - Gavi, the Vaccine Alliance
Arcturus: WHO upgrades XBB.1.16 to a COVID-19 “variant of interest” Gavi, the Vaccine Alliance
Altered receptor binding, antibody evasion and retention of T cell recognition by the SARS-CoV-2 ...
XBB.1.5 variant: What you need to know now with Andrea Garcia, JD, MPH | AMA Update Video | AMA -...
XBB.1.5 variant: What you need to know now with Andrea Garcia, JD, MPH | AMA Update Video | AMA American Medical Association
Characteristics of the omicron XBB subvariant wave in Singapore - The Lancet
Characteristics of the omicron XBB subvariant wave in Singapore The Lancet
XBB COVID vaccine estimated to be 63% to 68% effective against more severe illness in kids - CIDRAP
XBB COVID vaccine estimated to be 63% to 68% effective against more severe illness in kids CIDRAP
Trivalent recombinant protein vaccine induces cross-neutralization against XBB lineage and JN.1 s...
Immunogenicity of Comirnaty Omicron XBB.1.5 booster COVID-19 mRNA vaccine in long-term survivors ...
Genomic surveillance and vaccine response to the dominant SARS-CoV-2 XBB lineage in Rio Grande do...
Updated COVID-19 Boosters and XBB.1.5: What You Need to Know - American Society for Microbiology
Updated COVID-19 Boosters and XBB.1.5: What You Need to Know American Society for Microbiology
How much should people worry about Covid’s XBB.1.5 variant? Our medical analyst explains - cnn.com
How much should people worry about Covid’s XBB.1.5 variant? Our medical analyst explains cnn.com
Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant - Nature
Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant Nature
From BQ.1.1 to XBB and beyond: How the splintering of Omicron variants could shape Covid's next p...
From BQ.1.1 to XBB and beyond: How the splintering of Omicron variants could shape Covid's next phase statnews.com
WHO issues initial Omicron XBB.1.16 risk assessment - CIDRAP
FDA recommends that updated Covid shots target omicron subvariant XBB.1.5 this fall - CNBC
FDA recommends that updated Covid shots target omicron subvariant XBB.1.5 this fall CNBC
XBB.1.5 is rapidly taking over the US. Here's what we know about the new COVID variant - TODAY.com
XBB.1.5 is rapidly taking over the US. Here's what we know about the new COVID variant TODAY.com
New XBB.1.5 COVID-19 variant spreading rapidly through U.S. - uclahealth.org
New XBB.1.5 COVID-19 variant spreading rapidly through U.S. uclahealth.org
Humoral immune responses to the monovalent XBB.1.5-adapted BNT162b2 mRNA booster in Sweden - The ...
Humoral immune responses to the monovalent XBB.1.5-adapted BNT162b2 mRNA booster in Sweden The Lancet
What You Need To Know About XBB.1.5, COVID’s Latest Variant - Texas A&M Stories
What You Need To Know About XBB.1.5, COVID’s Latest Variant Texas A&M Stories
Characterization of Omicron BA.4.6, XBB, and BQ.1.1 subvariants in hamsters | Communications Biol...
Characterization of Omicron BA.4.6, XBB, and BQ.1.1 subvariants in hamsters | Communications Biology Nature
Neutralization of SARS-CoV-2 BQ.1.1, CH.1.1, and XBB.1.5 by breakthrough infection sera from prev...
Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhum...
XBB booster offers protection against JN.1 infections, hospital cases, new data show - CIDRAP
XBB booster offers protection against JN.1 infections, hospital cases, new data show CIDRAP
COVID's latest twist: New XBB variant gains strength through recombination, outsmarting immunity ...
WHO advisers recommend switch to monovalent XBB COVID vaccine - CIDRAP
WHO advisers recommend switch to monovalent XBB COVID vaccine CIDRAP
SA is not facing a deadly Covid XBB wave or egg-related Salmonella outbreak, despite posts - News24
SA is not facing a deadly Covid XBB wave or egg-related Salmonella outbreak, despite posts News24
What Is XBB? New Infectious Omicron Variant, COVID - Business Insider
What Is XBB? New Infectious Omicron Variant, COVID Business Insider
Reported levels of global COVID-19 decrease as XBB.1.5 seen across Europe, US - CIDRAP
Reported levels of global COVID-19 decrease as XBB.1.5 seen across Europe, US CIDRAP
Omicron XBB.1.5: Heightened Transmissibility, Infectivity, and Immune Resistance - Contagion Live
Omicron XBB.1.5: Heightened Transmissibility, Infectivity, and Immune Resistance Contagion Live
WHO elevates XBB.1.16 to variant of interest as levels rise in US and other countries - CIDRAP
WHO elevates XBB.1.16 to variant of interest as levels rise in US and other countries CIDRAP
The Updated COVID-19 Shot Works on the Newest Variants - Time Magazine
The Updated COVID-19 Shot Works on the Newest Variants Time Magazine
Antiviral humoral immunity against SARS-CoV-2 omicron subvariants induced by XBB.1.5 monovalent v...
What is the XBB.1.5 subvariant? CDC reports a new strain of omicron taking over in the U.S. - NBC...
What is the XBB.1.5 subvariant? CDC reports a new strain of omicron taking over in the U.S. NBC News
How the latest Covid-19 variant is shaping the course of the pandemic - vox.com
How the latest Covid-19 variant is shaping the course of the pandemic vox.com
Genomic epidemiology and evolutionary analysis during XBB.1.16-predominant periods of SARS-CoV-2 ...
What to know about XBB.1.16, the 'Arcturus' variant - NBC News
What to know about XBB.1.16, the 'Arcturus' variant NBC News
Omicron XBB.1.5 variant expands US dominance - CIDRAP
Interim Effectiveness of Updated 2023–2024 ... - Centers for Disease Control and Prevention | CDC...
Interim Effectiveness of Updated 2023–2024 ... Centers for Disease Control and Prevention | CDC (.gov)
Highly immune evasive omicron XBB.1.5 variant is quickly becoming dominant in U.S. as it doubles ...
Latest XBB COVID-19 vaccine offers protection against hospitalization, deaths - CIDRAP
Latest XBB COVID-19 vaccine offers protection against hospitalization, deaths CIDRAP
Omicron XBB.1.5 'Kraken' Subvariant Is on the Rise: What To Know - Yale Medicine
Omicron XBB.1.5 'Kraken' Subvariant Is on the Rise: What To Know Yale Medicine
CDC: New, Highly Infectious COVID Variant Spreading Much Faster in NY, NJ Than US - NBC New York
CDC: New, Highly Infectious COVID Variant Spreading Much Faster in NY, NJ Than US NBC New York
Neutralization of SARS-CoV-2 Omicron BQ.1, BQ.1.1 and XBB.1 variants following SARS-CoV-2 infecti...
From Centaurus to XBB: your handy guide to the latest COVID subvariants (and why some are more wo...
From Centaurus to XBB: your handy guide to the latest COVID subvariants (and why some are more worrying than others) The Conversation
F.D.A. Panel Advises Vaccine Makers to Aim at Only One Covid Variant (Published 2023) - The New Y...
F.D.A. Panel Advises Vaccine Makers to Aim at Only One Covid Variant (Published 2023) The New York Times
Clinical profile analysis of SARS-CoV-2 community infections during periods with omicron BA.2, BA...
New COVID-19 PCR Test Launched to Detect XBB.1.5 Omicron Sub-Variant - Pharmacy Times
New COVID-19 PCR Test Launched to Detect XBB.1.5 Omicron Sub-Variant Pharmacy Times
Neutralisation sensitivity of the SARS-CoV-2 XBB.1 lineage - The Lancet
Neutralisation sensitivity of the SARS-CoV-2 XBB.1 lineage The Lancet
The ‘Kraken’ subvariant XBB.1.5 sounds scary. But behind the headlines are clues to where COVID’s...
The ‘Kraken’ subvariant XBB.1.5 sounds scary. But behind the headlines are clues to where COVID’s heading The Conversation
Vaccines are not making COVID strains like ‘Kraken’ stronger. Here’s how the four shots battle va...
Omicron Subvariant XBB.1.5: What to Know - NewYork-Presbyterian - Health Matters
Omicron Subvariant XBB.1.5: What to Know NewYork-Presbyterian - Health Matters
CDC tracking rapid rise of new XBB.1.5 COVID variant, not yet a majority nationwide - cbsnews.com
CDC tracking rapid rise of new XBB.1.5 COVID variant, not yet a majority nationwide cbsnews.com